Pharmacoeconomic evaluation of tocilizumab monotherapy vs. Adalimumab monotherapy in reducing disease activity in patients with rheumatoid arthritis

dc.contributor.author	BLANCO GARCIA, FRANCISCO JAVIER
dc.date.accessioned	2017-06-07T07:32:26Z
dc.date.available	2017-06-07T07:32:26Z
dc.date.issued	2012
dc.identifier.issn	0004-3591
dc.identifier.uri	http://hdl.handle.net/20.500.11940/7692
dc.language.iso	eng
dc.title	Pharmacoeconomic evaluation of tocilizumab monotherapy vs. Adalimumab monotherapy in reducing disease activity in patients with rheumatoid arthritis
dc.type	Publicación de congreso
dc.authorsophos	Navarro Sarabia, F.
dc.authorsophos	Blanco, F. J.
dc.authorsophos	Alvaro Gracia, J. M.
dc.authorsophos	Meijide, J. A. G.
dc.authorsophos	Poveda, J. L.
dc.identifier.isi	WOS:000309748305093
dc.identifier.sophos	7682
dc.journal.title	ARTHRITIS AND RHEUMATISM
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña::INIBIC.- Instituto de Investigación Biomédica
dc.rights.accessRights	openAccess
dc.typesophos	Comunicaciones a congresos
dc.volume.number	64

Files in this item

Files	Size	Format	View
There are no files associated with this item.